CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. R&D Expense

Quick Answer

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported R&D Expense of $2.26 million for fiscal year 2025.

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. R&D Expense — Annual History

Fiscal Year R&D Expense YoY Change
2025 $2.26M -5.9%
2024 $2.40M +21.8%
2023 $1.97M -60.6%
2023 $5.00M -20.2%
2022 $6.27M +25.4%
2022 $5.00M +4479.6%
2021 $109.2K
2020 $0.00
2019 $0.00 -100.0%
2018 $96.6K -62.9%
2017 $260.1K +204.8%
2016 $85.3K
2015 $0.00

Quarterly R&D Expense

Quarter Ending R&D Expense YoY QoQ
September 30, 2025 $465.2K -20.0% -7.2%
June 30, 2025 $501.3K -45.8% -32.6%
March 31, 2025 $743.3K +76.0% +27.8%
September 30, 2024 $581.8K -41.4% -37.1%
June 30, 2024 $924.7K +198.8% +118.9%
March 31, 2024 $422.4K +32.4% -57.5%
September 30, 2023 $992.7K +329.9% +220.8%
June 30, 2023 $309.5K -53.1% -3.0%
  • CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. showed a decrease of -5.9% in R&D Expense compared to the prior fiscal year.
  • The most recent figure is from CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment